Medicare & Coverage
Clinical Guidance
This page contains affiliate links. We may earn a commission at no extra cost to you — see full disclosure below.
The Medicare GLP-1 Bridge: A Clinical Eligibility Breakdown for Prescribers and Patients
The Medicare GLP-1 Bridge, launched July 1, 2026, has specific clinical eligibility criteria that both prescribers and patients should understand precisely — not just the headline $50 copay figure.
The clinical criteria that actually matter
- BMI documentation meeting the program's weight-management threshold
- Prescription for an FDA-approved brand-name medication specifically — compounded formulations don't qualify since Medicare requires an assigned NDC
- A participating Part D plan — not universal across all plans at launch
Clinical note for prescribers: Documentation quality matters here — specific comorbidity coding alongside BMI documentation supports a stronger case than a vague obesity code alone, consistent with general prior authorization best practice.
Sesame Care From $29
Prescribes FDA-approved brand-name medications compatible with Medicare Bridge eligibility.
Prescribes FDA-approved brand-name medication only. Not a compounded provider.
Visit Sesame Care →Paid link
Care Bare Rx Custom
Ongoing clinician support that can help navigate eligibility questions and documentation.
Visit Care Bare Rx →Paid linkFor patients navigating this with their provider
Confirm your specific Part D plan's Bridge participation status directly through Medicare.gov before assuming the $50 copay applies to your situation — plan-level variation is real, and a prescriber can't override that variation.
Important: GLP-1 Doc earns affiliate commissions when you visit a provider through our links. This does not affect pricing or your care. Provider mentions are editorial. We are not a healthcare provider and do not prescribe medications. Always verify a provider's licensing in your state before starting treatment. Medical Disclaimer: Content is for informational purposes only and is not medical advice. Always consult a licensed healthcare provider before starting, stopping, or changing any medication. Compounded GLP-1 medications are not FDA-approved.